S L Hoti
Overview
Explore the profile of S L Hoti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
795
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muthukumaran U, Govindarajan M, Rajeswary M, Hoti S
Parasitol Res
. 2024 Nov;
123(11):385.
PMID: 39549148
No abstract available.
2.
Singh I, Hoti S, Chauhan N, Joshi R, Keshava Prasad T, Sarikhani M, et al.
Acta Trop
. 2024 Feb;
252:107142.
PMID: 38331083
Helminth parasites modulate the host immune system to ensure a long-lasting asymptomatic form of infection generally, mediated by the secretion of immunomodulatory molecules and one such molecule is a homologue...
3.
Sabesan S, Krishnamoorthy K, Hoti S, Subramanian S, Srividya A, Roy N, et al.
Indian J Med Res
. 2022 Sep;
155(3&4):347-355.
PMID: 36124509
Lymphatic filariasis (LF) is a vector-borne neglected tropical disease, causing permanent disability. The disease is debilitating and widespread, leading to tremendous productivity and economic loss. The Government of India (GOI)...
4.
Chellappan S, Roy S, Nagmoti J, Tabassum W, Vukanti R, Hoti S, et al.
J Vector Borne Dis
. 2021 Dec;
57(4):325-330.
PMID: 34856712
Background And Objectives: The mitochondrial electron transport chain (mtETC) of Plasmodium falciparum is an important drug target. Identification and functional validation of putative mitochondrial proteins of the mtETC is critical...
5.
Kumar N, Kumar A, Panneer D, Abidha S, Muthukumaravel S, Sankari T, et al.
Int J Infect Dis
. 2021 Oct;
113:119-124.
PMID: 34601144
Objectives: Following the Public Health Emergency of International Concern declared on Zika by the World Health Organization during 2016, the Indian Council of Medical Research carried out nationwide vector surveillance...
6.
Govindarajan M, Rajeswary M, Veerakumar K, Muthukumaran U, Hoti S, Mehlhorn H, et al.
Parasitol Res
. 2021 Sep;
120(10):3631.
PMID: 34480203
No abstract available.
7.
Asaaga F, Young J, Oommen M, Chandarana R, August J, Joshi J, et al.
BMC Public Health
. 2021 Aug;
21(1):1517.
PMID: 34362321
Background: There is a strong policy impetus for the One Health cross-sectoral approach to address the complex challenge of zoonotic diseases, particularly in low/lower middle income countries (LMICs). Yet the...
8.
Devendra R, Gupta V, Shanmugam R, Singh M, Patel P, Valecha N, et al.
Infect Genet Evol
. 2020 Oct;
86:104597.
PMID: 33069889
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most common human erythroenzymopathy affecting around 10% of the world population. India is endemic for malaria and antimalarial drugs are known...
9.
Chellappan S, Roy S, Nagmoti J, Tabassum W, Hoti S, Bhattacharyya M, et al.
Indian J Med Microbiol
. 2020 Sep;
38(2):213-215.
PMID: 32883936
Prohibitins (PHBs) are evolutionarily conserved mitochondrial integral membrane proteins, shown to regulate mitochondrial structure and function, and can be classified into PHB1 and PHB2. PHB1 and PHB2 have been shown...
10.
Devendra R, Gupta V, Biradar S, Bhat P, Hegde S, Hoti S, et al.
Ann Hum Biol
. 2019 Dec;
47(1):55-58.
PMID: 31833391
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human erythroenzymopathy affecting more than 400 million people worldwide. G6PD deficiency was reported in India more than 50 years ago and the...